| 标题 |
Safety, efficacy, & pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study
口服RIG-I激动剂伊那吉韦（IRIG）联合替诺福韦阿拉酚胺48周治疗成人慢性乙型肝炎患者的安全性、有效性和药效学（PD）活性：一项2期合作研究
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | The International Liver Congress: European Association for the Study of the Liver (EASL) Virtual; 2021 23-26 June.；Lim YS, Hui AJ, Jang JW, Tak WY, Ahn SH, Jang BK, et al |
| 求助人 | |
| 下载 |
cdercder
eee
冰魂
bc
SYLH
不倦
昏睡的蟠桃
pluto
科研助手6
遇上就这样吧
YifanWang
余味
HeWang
科研小民工
小墨
归尘
dodo
路人
iNk
aprilvanilla
皖公网安备34019202002308
